Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 17, 2020
- Accepted April 5, 2021
- Published online May 13, 2021.
Copyright & Usage
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Alyn Morice1⇑,
- Jaclyn A. Smith2,
- Lorcan McGarvey3,
- Surinder S. Birring4,
- Sean M. Parker5,
- Alice Turner6,
- Thomas Hummel7,
- Isabella Gashaw8,
- Lueder Fels8,
- Stefan Klein8,
- Klaus Francke8 and
- Christian Friedrich8
- 1Respiratory Research Group, Hull York Medical School, University of Hull, Hull, UK
- 2Manchester University NHS Foundation Trust, and Manchester Academic Health Science Centre, Manchester, UK
- 3Wellcome Wolfson Institute of Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK
- 4Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College Hospital, London, UK
- 5North Tyneside Hospital, Northumbria Healthcare NHS Foundation Trust, North Shields, UK
- 6Institute of Applied Health Research and Population Sciences, University of Birmingham, Birmingham, UK
- 7Smell & Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany
- 8Bayer AG, Berlin, Germany
- Alyn Morice, Respiratory Research Group, Hull York Medical School, University of Hull, Cottingham, Hull, East Yorkshire, HU16 5JQ, UK. E-mail: a.h.morice{at}hull.ac.uk
Funding
Bayer
Article usage
Altmetrics
Vol 61 Issue 1
Table of Contents
Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
